Literature DB >> 1032575

[Clinicopharmacological studies with pindolol following intravenous and oral administration].

W H Aellig.   

Abstract

The beta-adrenoceptor blocking potency of pindolol after intravenous and after oral administration was compared in clinical pharmacological experiments in healthy volunteers. Equal doses of pindolol were aequiactive 75 min after intravenous and 2 h after oral administration on tachycardia due to isoprenaline infusions as well as on tachycardia due to exercise on the cycle ergometer. The results of this comparison of pharmacodynamic effects confirm the good enteral absorption reported in pharmacokinetic studies.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1032575

Source DB:  PubMed          Journal:  Adv Clin Pharmacol        ISSN: 0303-2671


  3 in total

Review 1.  Pindolol--a beta-adrenoceptor blocking drug with partial agonist activity: clinical pharmacological considerations.

Authors:  W H Aellig
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

2.  A pharmacodynamic and pharmacokinetic comparison of pindolol 20 mg retard and a conventional tablet.

Authors:  W H Aellig; H H Narjes; E Nüesch; R J Oertle; J E Devos; W Pacha
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

3.  Contrasts between pindolol and propranolol concentration-response relationships.

Authors:  S G Carruthers; W L Pacha; W H Aellig
Journal:  Br J Clin Pharmacol       Date:  1985-10       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.